Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization

Background. The persistence of protection from meningococcal disease following immunization with serogroup C meningococcal (MenC) glycoconjugate vaccines in infancy is short-lived. The duration of protective immunity afforded by these vaccines in other at-risk age groups (i.e., adolescents and young...

Full description

Bibliographic Details
Main Authors: Snape, M, Kelly, D, Salt, P, Green, S, Snowden, C, Diggle, L, Borkowski, A, Yu, L, Moxon, E, Pollard, A
Other Authors: Infectious Diseases Society of America
Format: Journal article
Language:English
Published: University of Chicago Press 2006
Subjects: